Loading...
NPI 1306820360 · Conway, AR · Retina Specialist (Ophthalmology) Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Stephen Magie is a retina specialist (ophthalmology) physician provider located in Conway, Arkansas. This profile covers 13 Medicare and 1 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Stephen Magie |
| Address | 924 Main St |
| City | Conway |
| State | AR |
| ZIP | 72032 |
| Taxonomy | Retina Specialist (Ophthalmology) Physician |
| NPI Enumerated | December 2, 2005 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $1.5M |
| Medicaid | $2.2K |
Provider tenure and payer scale: STEPHEN MAGIE has an NPI enumerated 2005-12-02 (~21 years ago) and shows a Medicare-dominant billing profile with $1.5M in lifetime Medicare revenue versus only $2.2K in lifetime Medicaid revenue, indicating the provider operates effectively as a Medicare-focused retina specialist at this scale. The Medicaid footprint is negligible in absolute dollars compared with Medicare.
Revenue concentration in Medicare: the provider’s Medicare billing is highly concentrated in a small number of high-value codes — the precomputed top 3 Medicare codes account for 85.1% of total Medicare revenue. Those top three are J2777 ($668.2K, 45.7% of Medicare revenue), J0178 ($499.9K, 34.2%), and 67028 ($76.4K, 5.2%), showing most Medicare receipts derive from intravitreal drug administration and a single injection procedure code.
Medicaid concentration and modality: all reported Medicaid revenue (100.0% of $2.2K) is from a single code, 92134, which bills for computerized diagnostic retinal imaging. This indicates the provider’s Medicaid activity is very narrowly focused on retinal imaging rather than the drug administration that drives Medicare revenue.
Business/service-line implications: the dominant Medicare codes (J2777 and J0178) are injections of faricimab and aflibercept, respectively, and together with the presence of J2778 and 67028 indicate the practice’s core operation is intravitreal pharmacologic therapy for retinal disease supplemented by injections as isolated procedures. High-volume retinal imaging (92134) and intermediate/comprehensive ophthalmologic exams (92012, 92004, 92014) in the Medicare mix suggest the practice combines therapeutic injection visits with diagnostic imaging and office-based follow-up care.
Competitive standing on injection drugs: J2777 ($668.2K) ranks #439 of 2039 nationally (78th percentile) and is labeled typical/unremarkable volume, while J0178 ($499.9K) ranks #1583 of 3204 (51st percentile) and is also typical/unremarkable. These rank positions indicate the provider is an active but not dominant national participant in billing these anti-VEGF/faricimab therapies — a meaningful local operator rather than a regional or national leader for these drugs.
Diagnostic and exam volume vs. national peers: several non-drug codes are reported at notably above-typical national volume — 92012 (893 claims, $50.9K) ranks in the 96th percentile and 92134 (1.7K claims, $43.8K) ranks in the 95th percentile for Medicare. Those elevated percentiles imply relatively high throughput of established-patient intermediate exams and retinal imaging compared with national ophthalmology peers, consistent with an established patient panel receiving ongoing retina care.
Limited Medicaid competitiveness in-state: the Medicaid 92134 activity (55 claims, $2.2K) ranks #36 of 43 in-state (17th percentile) and is described as typical/unremarkable for that peer group. This low in-state percentile combined with the very small Medicaid dollar volume suggests constrained participation in the Arkansas Medicaid market or a practice mix that does not rely on Medicaid referrals.
Breadth of ancillary services: beyond the injection-dominated revenue, the provider bills a range of ancillary retina/ophthalmology services at lower dollar levels — examples include 67028 ($76.4K), J2778 ($58.2K), 92004 ($20K), J7999 ($12.6K), and 67228 ($6.9K). These entries show the practice offers a mix of therapeutic injections, diagnostic imaging, in-office comprehensive evaluations, occasional compounded drugs, and laser procedures, indicating typical retina-specialist breadth beyond the primary drug-delivery business line.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
13 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| J2777 | Injection, faricimab‑svoa, 0.1 mg | 23,040 | $30 | $668.2K |
| J0178 | Injection, aflibercept, 1 mg | 730 | $680 | $499.9K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 990 | $80 | $76.4K |
| J2778 | Injection, ranibizumab, 0.1 mg | 330 | $180 | $58.2K |
| 92012 | For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any… | 890 | $60 | $50.9K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 1,690 | $30 | $43.8K |
| 92004 | The provider performs a comprehensive level ophthalmological evaluation of a new patient and initiates a diagnostic and treatment program for one or more visits. | 210 | $100 | $20K |
| 92014 | An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group… | 240 | $80 | $19.8K |
| J7999 | Compounded drug, not otherwise classified | 200 | $60 | $12.6K |
| 67228 | In retinopathy, tiny new vessels grow profusely and fibrous tissue proliferates in between the layers of the retina, which may extend into the optic nerve and vitreous, clear gel that fills the space… | 30 | $240 | $6.9K |
Showing 1–10 of 13
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 13 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
13 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| J0178 | 13 | 30 | 390 | $690 | $538.3K |
| J2777 | 7 | 20 | 12,180 | $30 | $504.5K |
| J2778 | 7 | 20 | 270 | $180 | $85K |
| 67028 | 12 | 40 | 270 | $80 | $51.1K |
| J7999 | 10 | 30 | 100 | $130 | $20.6K |
| 92014 | 122 | 370 | 150 | $70 | $19.1K |
| 92012 | 8 | 220 | 70 | $50 | $9.3K |
| 67228 | 6 | 10 | 30 | $230 | $8.8K |
| 92004 | 20 | 310 | 40 | $90 | $6.2K |
| 92134 | 12 | 300 | 70 | $30 | $6K |
Showing 1–10 of 13
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
1 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 60 | $40 | $2.2K |
How this provider's Medicaid billing volume and revenue compare to other Arkansas providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Arkansas median
1 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 36 | 40 | 260 | $20 | $26.2K |
Other providers in the same ZIP code as Stephen Magie, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.